Clinical significance of heat shock protein-70 expression in bladder cancer

Urology. 2003 Mar;61(3):677-80. doi: 10.1016/s0090-4295(02)02289-6.

Abstract

Objectives: To investigate the expression of heat shock protein-70 (HSP-70) in transitional cell bladder cancer and correlate it with normal and inflammatory bladder tissue samples.

Methods: We used a three-step avidin-biotin method to examine the localization of a rabbit anti-HSP-70 polyclonal antibody in normal (n = 10), inflammatory (n = 10), and malignant (n = 67) bladder tissue samples.

Results: Fifty-eight percent of the bladder cancer samples and only 10% and 20% of the normal and inflammatory bladder tissue samples, respectively, expressed HSP-70. Localization of the antibody correlated with the grade (P <0.001), stage (P <0.001), and survival (P <0.05) of the patients with malignancy.

Conclusions: HSP-70 is frequently overexpressed by bladder cancer cells and could be used as biochemical marker in patients with bladder cancer.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Animals
  • Biomarkers, Tumor / metabolism
  • Carcinoma in Situ / diagnosis
  • Carcinoma in Situ / metabolism
  • Carcinoma, Transitional Cell / diagnosis
  • Carcinoma, Transitional Cell / metabolism*
  • Cystitis / metabolism*
  • Female
  • HSP70 Heat-Shock Proteins / metabolism*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Proteins / metabolism
  • Prognosis
  • Rabbits
  • Survival Analysis
  • Urinary Bladder / metabolism*
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / metabolism*

Substances

  • Biomarkers, Tumor
  • HSP70 Heat-Shock Proteins
  • Neoplasm Proteins